| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |